Stratum Biosciences, a biotechnology pioneer at the intersection of artificial intelligence and dermatology research, announced the closing of a $2M seed funding round backed by the Harvard Business School Alumni Angels of Greater New York and Skin Angels, the world's largest network of early-stage skin and dermatology investors.

Stratum was co-founded in 2024 by dermatologist Dr. Ross Lane Pearlman and dermatopathologist Dr. Buu Duong, both leaders in their specialties for integrating technology and AI into skin research and workflows. The investment will be used to scale the company's proprietary AI-powered skin biology discovery platform, mining over 200,000 real skin samples for novel insights and translating findings into accelerated product development.